Suppr超能文献

一种用于监管毒理学研究的体内 Pig-a 基因突变试验的特性分析。

Characterisation of an in vivo Pig-a gene mutation assay for use in regulatory toxicology studies.

作者信息

Godin-Ethier Jessica, Leroux Francis, Wang Nan, Thébaud Sybil, Merah Farida, Nelson Andrew

机构信息

ITR Laboratories Canada, Inc., 19601 Clark Graham, Baie d'Urfé (Montreal), Quebec H9X 3T1, Canada

ITR Laboratories Canada, Inc., 19601 Clark Graham, Baie d'Urfé (Montreal), Quebec H9X 3T1, Canada.

出版信息

Mutagenesis. 2015 May;30(3):359-63. doi: 10.1093/mutage/gev005. Epub 2015 Feb 13.

Abstract

Integration of in vivo genotoxicity testing into standard toxicology studies presents multiple advantages as it reduces animal use and costs, accelerates data generation and provides concurrent data that are useful for interpreting results. The in vivo Pig-a assay is a mammalian gene mutation assay that utilises peripheral blood and thus has a high integration potential. Although inter-laboratory reproducibility has been well demonstrated, further characterisation is required for this assay. In this study, we evaluated intra-laboratory reproducibility of the in vivo Pig-a gene mutation assay (MutaFlow® kit) in rats through the conduct of an assay characterisation prior to subsequent use in Good Laboratory Practices (GLP) toxicology studies. To evaluate intra-laboratory reproducibility, intra-assay and inter-assay variability, ruggedness, robustness and blood storage stability were assessed. These assessments were performed using blood obtained from male Sprague-Dawley rats exposed to 0, 20 or 40mg/kg/day N-ethyl-N-nitrosourea via oral gavage for three consecutive days. Blood was collected from these rats on multiple occasions from Day 29 to Day 71 and samples were analysed for Pig-a mutation using the rat MutaFlow kit. Frequencies of reticulocytes (RET), mutant phenotype erythrocytes (RBC(CD59-)) and mutant phenotype RET (RET(CD59-)) were determined. Overall, the proportion of RET and frequencies of RBC(CD59-) and of RET(CD59-) were consistent throughout the different assessments. The assay demonstrated acceptable intra-run and inter-run variability with coefficients of variation of ≤4.8 and 20.6%, respectively. The method was shown to be independent of the analyst performing the assay and unaffected by small changes in assay conditions. Comparable results were obtained from freshly collected samples and samples refrigerated for up to 4 days. Although technically challenging, the rat Pig-a gene mutation assay using a high-throughput automated method was shown to be reliable. The different assay parameters evaluated during the conduct of this study yielded acceptable results. Thus, the method was considered suitable for use in GLP toxicology studies.

摘要

将体内遗传毒性测试整合到标准毒理学研究中具有诸多优势,因为它减少了动物使用量和成本,加快了数据生成速度,并提供了有助于解释结果的同步数据。体内Pig-a试验是一种利用外周血的哺乳动物基因突变试验,因此具有很高的整合潜力。尽管实验室间的可重复性已得到充分证明,但该试验仍需要进一步的特性描述。在本研究中,我们通过在后续的良好实验室规范(GLP)毒理学研究中使用之前进行试验特性描述,评估了大鼠体内Pig-a基因突变试验(MutaFlow®试剂盒)的实验室内可重复性。为了评估实验室内可重复性、批内和批间变异性、耐用性、稳健性和血液储存稳定性,我们进行了相关评估。这些评估使用的血液来自雄性Sprague-Dawley大鼠,这些大鼠通过口服灌胃连续三天暴露于0、20或40mg/kg/天的N-乙基-N-亚硝基脲。在第29天至第71天多次从这些大鼠身上采集血液,并使用大鼠MutaFlow试剂盒分析样本的Pig-a突变情况。测定了网织红细胞(RET)、突变表型红细胞(RBC(CD59-))和突变表型RET(RET(CD59-))的频率。总体而言,在不同评估中,RET的比例以及RBC(CD59-)和RET(CD59-)的频率是一致的。该试验显示出可接受的批内和批间变异性,变异系数分别≤4.8%和20.6%。结果表明该方法与进行试验的分析人员无关,并且不受试验条件微小变化的影响。新鲜采集的样本和冷藏长达4天的样本得到了可比的结果。尽管技术上具有挑战性,但使用高通量自动化方法的大鼠Pig-a基因突变试验被证明是可靠的。在本研究过程中评估的不同试验参数产生了可接受的结果。因此,该方法被认为适用于GLP毒理学研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验